Abn Amro Investment Solutions Biogen Inc. Transaction History

Abn Amro Investment Solutions

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 04, 2025	BUY	$190.52 - $236.72 $403,521 - $501,372	2,118 New	2,118 $491 Million
Q1 2024 Sep 05, 2025	SELL	$212.02 - $267.71 $3.09 Million - $3.9 Million	-14,586 Closed	0 $0
Q4 2023 Sep 05, 2025	SELL	$222.59 - $267.94 $186,975 - $225,069	-840 Reduced 5.45%	14,586 $3.77 Billion
Q3 2023 Nov 07, 2025	BUY	$253.3 - $285.89 $3.91 Million - $4.41 Million	15,426 New	15,426 $3.96 Billion
Q3 2023 Sep 05, 2025	BUY	$253.3 - $285.89 $3.91 Million - $4.41 Million	15,426 New	15,426 $3.96 Billion

Q2 2023 Sep 05, 2025	SELL	$275.25 - $318.06 $340,209 - $393,122	-1,236 Closed	0 $0
Q1 2023 Sep 05, 2025	BUY	$256.56 - $292.34 $317,108 - $361,332	1,236 New	1,236 $344 Million

1,078

131M

3.77M

2.31M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $24.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

Stay updated on Abn Amro Investment Solutions with notifications on news.